LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Mean Relative Cell Count | Standard Error of the Mean for Relative Cell Count | Mean Relative Growth Rate | Standard Error of the Mean for Relative Growth Rate |
---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 0.9128 | 0.0794 | 0.8839 | 0.1059 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 0.8998 | 0.1082 | 0.8618 | 0.1489 |
MDA-MB-231 | Crizotinib | 0.37 | uM | LJP5 | 0.8038 | 0.0615 | 0.7359 | 0.0804 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 0.7174 | 0.0298 | 0.6167 | 0.0438 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 0.1675 | 0.0129 | -0.1273 | 0.0118 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 0.1700 | 0.0077 | -0.1240 | 0.0101 |
MDA-MB-231 | Dovitinib | 0.37 | uM | LJP5 | 0.6049 | 0.0465 | 0.4652 | 0.0618 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 1.0106 | 0.0310 | 1.0149 | 0.0425 |
MDA-MB-231 | Erlotinib | 0.37 | uM | LJP5 | 0.9634 | 0.0196 | 0.9505 | 0.0263 |
MDA-MB-231 | Foretinib | 0.37 | uM | LJP5 | 0.3550 | 0.0334 | 0.1256 | 0.0533 |
MDA-MB-231 | R406 | 0.37 | uM | LJP6 | 0.9007 | 0.0277 | 0.8661 | 0.0366 |
MDA-MB-231 | Pictilisib | 0.37 | uM | LJP6 | 0.7387 | 0.0069 | 0.6460 | 0.0127 |
MDA-MB-231 | Gefitinib | 0.37 | uM | LJP6 | 1.0121 | 0.0205 | 1.0159 | 0.0275 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP5 | 0.2736 | 0.0432 | 0.0151 | 0.0677 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP6 | 0.2741 | 0.0550 | 0.0155 | 0.0834 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP5 | 0.9225 | 0.0212 | 0.8952 | 0.0283 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP6 | 0.9121 | 0.0319 | 0.8808 | 0.0435 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 0.8917 | 0.0069 | 0.8535 | 0.0084 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 0.3092 | 0.0320 | 0.0635 | 0.0524 |
MDA-MB-231 | GSK 690693 | 0.37 | uM | LJP5 | 0.9193 | 0.0267 | 0.8914 | 0.0350 |
MDA-MB-231 | GW843682X | 0.37 | uM | LJP6 | 0.5055 | 0.0493 | 0.3304 | 0.0663 |
MDA-MB-231 | HG-5-113-01 | 0.37 | uM | LJP5 | 0.7421 | 0.0676 | 0.6520 | 0.0882 |
MDA-MB-231 | HG-5-88-01 | 0.37 | uM | LJP6 | 0.8021 | 0.0505 | 0.7332 | 0.0655 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 1.0093 | 0.0374 | 1.0117 | 0.0501 |
MDA-MB-231 | JNK-9L | 0.37 | uM | LJP6 | 0.5547 | 0.0249 | 0.3965 | 0.0388 |